跳至主要内容
临床试验/NCT02847533
NCT02847533Unknown不适用

Inflammatory Markers and Resistant Depression

Centre Hospitalier Universitaire de Besancon2 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2016年9月最近更新:
适应症

试验速览

阶段
不适用
入组人数
108
试验地点
2
主要终点
plasmatic concentration of Interleukin 6

研究概览

简要总结

This study focuses on blood inflammatory markers (pro-inflammatory cytokines, anti-inflammatory cytokines, monocytes costimulation molecules) in patients with resistant unipolar depression in comparison with non-resistant unipolar depressed patients.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Factorial
主要目的
Screening
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • group 1: Patients with resistant MDD (at least 2 failed treatments for the current episode) ,current treatment with IRS or IRSNA,
  • group 2: patients with MDD remission after response to an antidepressant treatment.

排除标准

  • comorbid somatic or psychiatric disorders: chronic or acute inflammatory diseases, previous treatment with brain stimulation for the current episode, legal protection

结局指标

主要结局

plasmatic concentration of Interleukin 6

时间窗: at patient inclusion

次要结局

  • concentration of proinflammatory cytokine(at patient inclusion)
  • concentration of antiinflammatory cytokine(at patient inclusion)
  • plasmatic concentration of Retinoid X receptor signaling pathway(at patient inclusion)
  • Expression rate of monocytes costimulation molecules(at patient inclusion)
  • functional polymorphisms of expression genes of inflammatory proteins(at patient inclusion)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验